Clinical Trial Results:
Pre- and Postoperative Imaging and Monitoring of Patients with Primary Hyperparathyroidism:
Preoperative imaging in primary hyperparathyroidism using dual-isotope subtraction scintigraphy (SPECT/CT) and 11C-Choline PET/CT
Summary
|
|
EudraCT number |
2018-000726-63 |
Trial protocol |
DK |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
03 Apr 2022
|
First version publication date |
03 Apr 2022
|
Other versions |
|
Summary report(s) |
11C-Choline PET/CT vs. 99mTc-MIBI/123Iodide Subtraction SPECT/CT for Preoperative Detection of Abnormal Parathyroid Glands in Primary Hyperparathyroidism: A Prospective, Single-Centre Clinical Trial Locating hyperfunctioning parathyroid glands using 11C-Choline PETCT an inter- and intra-observer variation study Preoperative imaging in primary hyperparathyroidism Are11C‐Choline PETCT and 99mTc‐MIBI123Iodide subtraction SPECT CT interchangeable or do they supplement each other? |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.